US Patent Issued to ECUPHAR on Jan. 28 for "Pyrazoline-derived compound for use in the prevention and/or treatment of pain and inflammation associated to surgery in mammals" (Spanish Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,085, issued on Jan. 28, was assigned to ECUPHAR NV (Belgium).

"Pyrazoline-derived compound for use in the prevention and/or treatment of pain and inflammation associated to surgery in mammals" was invented by Homedes Beguer Josep Manel (Barcelona, Spain) and Salichs Florensa Marta (Barcelona, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of treating or preventing pain and inflammation associated to surgery in a mammal by administering the compound E-6087 to the mammal."

The patent was filed on May 31, 2022, under Application No. 17/828,297.

*For further information, including images, charts and tabl...